Tubal ectopic pregnancy (TEP) is a common gynaecological emergency. Several medical and surgical treatment options exist, but it is not clear which is the safest and most effective treatment.
In this study published in the British Journal of Obstetrics and Gynaecology , Dr Wattar and the EVIE research group conducted a network meta-analysis comparing all available treatments for women with a tubal ectopic pregnancy including data from 31 randomised trials. Our findings suggest that there is no evidence to support the routine use of Methotrexate for the management of Tubal Ectopic pregnancy as it does not offer better resolution rate than simple expectant management. Surgery remains the most effective treatment option.